Perras B - Search Results

1

Intranasal atrial natriuretic peptide acts as central nervous inhibitor of the hypothalamo-pituitary-adrenal stress system in humans.

Perras B, Schultes B, Behn B, Dodt C, Born J, Fehm HL. Perras B, et al. J Clin Endocrinol Metab. 2004 Sep;89(9):4642-8. doi: 10.1210/jc.2004-0089. J Clin Endocrinol Metab. 2004. PMID: 15356075 Clinical Trial.

2

Growth hormone-releasing hormone facilitates hypoglycemia-induced release of cortisol.

Perras B, Schultes B, Schwaiger R, Metz C, Wesseler W, Born J, Fehm HL. Perras B, et al. Regul Pept. 2002 Dec 31;110(1):85-91. doi: 10.1016/s0167-0115(02)00163-5. Regul Pept. 2002. PMID: 12468113 Clinical Trial.

3

Improvement of sleep and pituitary-adrenal inhibition after subchronic intranasal vasopressin treatment in elderly humans.

Perras B, Wagner U, Born J, Fehm HL. Perras B, et al. J Clin Psychopharmacol. 2003 Feb;23(1):35-44. doi: 10.1097/00004714-200302000-00007. J Clin Psychopharmacol. 2003. PMID: 12544374 Clinical Trial.

4

Sleep and endocrine changes after intranasal administration of growth hormone-releasing hormone in young and aged humans.

Perras B, Marshall L, Köhler G, Born J, Fehm HL. Perras B, et al. Psychoneuroendocrinology. 1999 Oct;24(7):743-57. doi: 10.1016/s0306-4530(99)00027-x. Psychoneuroendocrinology. 1999. PMID: 10451909 Clinical Trial.

5

Melatonin does not inhibit hypothalamic-pituitary-adrenal activity in waking young men.

Perras B, Ozcan S, Fehm HL, Born J. Perras B, et al. J Neuroendocrinol. 2005 Dec;17(12):811-6. doi: 10.1111/j.1365-2826.2005.01373.x. J Neuroendocrinol. 2005. PMID: 16280028 Clinical Trial.

6

PreproTRH(158-183) fails to affect pituitary-adrenal response to CRH/vasopressin in man: a pilot study.

Perras B, Berkemeier E, Rasch B, Fehm HL, Born J. Perras B, et al. Neuropeptides. 2007 Aug;41(4):233-8. doi: 10.1016/j.npep.2007.03.002. Epub 2007 May 7. Neuropeptides. 2007. PMID: 17482675

7

Post-trial administration of vasopressin in humans does not enhance memory formation (vasopressin and memory consolidation).

Gais S, Sommer M, Fischer S, Perras B, Born J. Gais S, et al. Among authors: perras b. Peptides. 2002 Mar;23(3):581-3. doi: 10.1016/s0196-9781(01)00625-8. Peptides. 2002. PMID: 11836010 Clinical Trial.

8

Effects of cortisol suppression on sleep-associated consolidation of neutral and emotional memory.

Wagner U, Degirmenci M, Drosopoulos S, Perras B, Born J. Wagner U, et al. Among authors: perras b. Biol Psychiatry. 2005 Dec 1;58(11):885-93. doi: 10.1016/j.biopsych.2005.05.008. Epub 2005 Jul 7. Biol Psychiatry. 2005. PMID: 16005438 Clinical Trial.

9

Towards the therapeutic use of intranasal neuropeptide administration in metabolic and cognitive disorders.

Hallschmid M, Benedict C, Schultes B, Perras B, Fehm HL, Kern W, Born J. Hallschmid M, et al. Among authors: perras b. Regul Pept. 2008 Aug 7;149(1-3):79-83. doi: 10.1016/j.regpep.2007.06.012. Epub 2008 Mar 25. Regul Pept. 2008. PMID: 18442862

10

A role for central nervous growth hormone-releasing hormone signaling in the consolidation of declarative memories.

Hallschmid M, Wilhelm I, Michel C, Perras B, Born J. Hallschmid M, et al. Among authors: perras b. PLoS One. 2011;6(8):e23435. doi: 10.1371/journal.pone.0023435. Epub 2011 Aug 5. PLoS One. 2011. PMID: 21850272 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters